Patient Guide: A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 29 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05936359
Status: 🟢 Enrolling Now
Condition: Myeloproliferative Neoplasms
Phase: PHASE1

Where You Can Participate

This study is available at 29 locations across the country.

Top locations include:
  • • Herston, Queensland
  • • Adelaide, South Australia
  • • Melbourne, Victoria
  • • And 26 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms - Join Clinical Trial NCTNCT05936359

How to Join This Clinical Trial - NCTNCT05936359

Learn how to participate in this PHASE1 trial studying an investigational therapy for Myeloproliferative Neoplasms. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Myeloproliferative Neoplasms. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Myeloproliferative Neoplasms
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05936359 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 29 locations. Find a study site near you:

Clinical Research Site

Herston, Queensland 04029 - Australia

Status: RECRUITING

Clinical Research Site

Adelaide, South Australia 05000 - Australia

Status: RECRUITING

Clinical Research Site

Melbourne, Victoria 03000 - Australia

Status: RECRUITING

Clinical Research Site

Melbourne, Victoria 03004 - Australia

Status: RECRUITING

Clinical Research Site

Toronto, Ontario M5G 2M9 - Canada

Status: RECRUITING

Clinical Research Site

Montreal, Quebec QC H1T 2M4 - Canada

Status: RECRUITING

Clinical Research Site

Odense C, 05000 - Denmark

Status: WITHDRAWN

Clinical Research Site

Roskilde, 04000 - Denmark

Status: RECRUITING

Clinical Research Site

Vejle, 07100 - Denmark

Status: RECRUITING

Clinical Research Site

Bordeaux, 33076 - France

Status: RECRUITING

And 19 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Myeloproliferative Neoplasms:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships